Back to top
more

GoodRx (GDRX)

(Real Time Quote from BATS)

$7.60 USD

7.60
340,796

+0.38 (5.26%)

Updated May 30, 2024 11:46 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (97 out of 250)

Industry: Medical Services

Better trading starts here.

Zacks News

Labcorp (LH) to Report Q4 Earnings: What's in the Cards?

Labcorp's (LH) fourth-quarter 2023 performance is likely to have demonstrated strength across its core businesses.

Will High Medical Costs Affect Centene's (CNC) Q4 Earnings?

Centene's (CNC) fourth-quarter results are likely to reflect growth in premiums and overall memberships.

How Much Upside is Left in GoodRx Holdings, Inc. (GDRX)? Wall Street Analysts Think 27.83%

The consensus price target hints at a 27.8% upside potential for GoodRx Holdings, Inc. (GDRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Cigna (CI) to Report Q4 Earnings: Can Rising Expenses Hurt?

Cigna's (CI) fourth-quarter results are likely to reflect growth in Evernorth revenues and customer base.

STERIS (STE) Set to Post Q3 Earnings: What's in the Cards?

STERIS' (STE) third-quarter fiscal 2024 results are likely to reflect solid performance across both the Healthcare and AST segments.

Can Higher Costs Affect HCA Healthcare's (HCA) Q4 Earnings?

HCA Healthcare's (HCA) fourth-quarter results are likely to reflect increased admissions and a lower average length of stay.

Earnings Estimates Rising for GoodRx Holdings, Inc. (GDRX): Will It Gain?

GoodRx Holdings, Inc. (GDRX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

What Makes GoodRx Holdings, Inc. (GDRX) a Strong Momentum Stock: Buy Now?

Does GoodRx Holdings, Inc. (GDRX) have what it takes to be a top stock pick for momentum investors? Let's find out.

GoodRx Holdings, Inc. (GDRX) Surges 13.3%: Is This an Indication of Further Gains?

GoodRx Holdings, Inc. (GDRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

ELV vs. GDRX: Which Stock Is the Better Value Option?

ELV vs. GDRX: Which Stock Is the Better Value Option?

Compared to Estimates, GoodRx Holdings, Inc. (GDRX) Q3 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for GoodRx Holdings, Inc. (GDRX) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Waters (WAT) Q3 Earnings Beat Estimates, Revenues Rise Y/Y

Waters' (WAT) Q3 results benefit from a strong Pharmaceutical market, as well as a strong contribution from the Wyatt acquisition.

Avantor, Inc. (AVTR) Q3 Earnings Meet Estimates

Avantor, Inc. (AVTR) delivered earnings and revenue surprises of 0% and 1.22%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

ICLR vs. GDRX: Which Stock Is the Better Value Option?

ICLR vs. GDRX: Which Stock Is the Better Value Option?

Down -11.5% in 4 Weeks, Here's Why You Should You Buy the Dip in GoodRx Holdings, Inc. (GDRX)

The heavy selling pressure might have exhausted for GoodRx Holdings, Inc. (GDRX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

ICLR vs. GDRX: Which Stock Should Value Investors Buy Now?

ICLR vs. GDRX: Which Stock Is the Better Value Option?

ICLR or GDRX: Which Is the Better Value Stock Right Now?

ICLR vs. GDRX: Which Stock Is the Better Value Option?

Walgreens (WBA) and VillageMD Expand Partnership in Chicago

Walgreens (WBA) and VillageMD's coordinated primary care and pharmacy services are now available in Chicago.

GoodRx Holdings, Inc. (GDRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for GoodRx Holdings, Inc. (GDRX) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

GoodRx Holdings, Inc. (GDRX) Beats Q2 Earnings and Revenue Estimates

GoodRx Holdings, Inc. (GDRX) delivered earnings and revenue surprises of 16.67% and 1.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Alignment Healthcare (ALHC) Reports Q2 Loss, Tops Revenue Estimates

Alignment Healthcare (ALHC) delivered earnings and revenue surprises of 28.57% and 5.84%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

ICLR or GDRX: Which Is the Better Value Stock Right Now?

ICLR vs. GDRX: Which Stock Is the Better Value Option?

GoodRx Holdings, Inc. (GDRX) Soars 21.5%: Is Further Upside Left in the Stock?

GoodRx Holdings, Inc. (GDRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

GoodRx Holdings, Inc. (GDRX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for GoodRx Holdings, Inc. (GDRX) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.